Evidence map›Paper›PMID 36012360›Full record

ArticleInternational journal of molecular sciences2022

NH

Dalma Dojcsák, Ágnes Mária Ilosvai, László Vanyorek, Ibolya Gilányi, Csaba Oláh, László Horváth, Csaba Váradi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. PlasmaNeurology(R) neuroimmunology & neuroinflammation · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dalma DojcsákAdvanced Materials and Intelligent Technologies Higher Education and Industrial Cooperation Centre, University of Miskolc, 3515 Miskolc, Hungary.
Ágnes Mária IlosvaiInstitute of Chemistry, Faculty of Materials Science and Engineering, University of Miskolc, 3515 Miskolc, Hungary.
László VanyorekInstitute of Chemistry, Faculty of Materials Science and Engineering, University of Miskolc, 3515 Miskolc, Hungary.ORCID 0000-0002-0630-0595
Ibolya GilányiBorsod-Abaúj-Zemplén County Center Hospital and University Teaching Hospital, Miskolc, 3526 Miskolc, Hungary.
Csaba OláhBorsod-Abaúj-Zemplén County Center Hospital and University Teaching Hospital, Miskolc, 3526 Miskolc, Hungary.
László HorváthBorsod-Abaúj-Zemplén County Center Hospital and University Teaching Hospital, Miskolc, 3526 Miskolc, Hungary.
Csaba VáradiAdvanced Materials and Intelligent Technologies Higher Education and Industrial Cooperation Centre, University of Miskolc, 3515 Miskolc, Hungary.ORCID 0000-0002-2672-095X
University of Miskolc · HUBorsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház · HU

Funding

European Regional Development Fund GINOP-2.3.4-15-2016-00004
6 · The paper itself

Abstract

Glycosylation is vital for well-functioning glycoproteins and is reportedly altered in chronic inflammatory disorders, including multiple sclerosis (MS). High-throughput quantitative measurement of protein glycosylation is challenging, as glycans lack fluorophore groups and require fluorescent labeling. The attachment of fluorescent tags to each glycan moiety necessitates sample clean-up for reliable quantitation. The use of magnetic particles in glycan sample preparation is reportedly an easy-to-use solution to accomplish large-scale biomarker discovery studies. In this study, NH

Indexed as

Magnetite NanoparticlesMultiple SclerosisGlycomicsGlycosylationHumansPolysaccharidesMagnetite NanoparticlesPolysaccharidesliquid chromatographymagnetic nanoparticlesmass spectrometrymultiple sclerosis

Identifiers

PMID36012360
PMCPMC9409089
OpenAlexW4292068905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.